35 investors have funded 9 Genomics companies head-officed in Austin, across 52 rounds (May 2003 – Aug 2025). They are ranked by how many Austin companies in this market they have actually backed.
"In Austin" describes the companies, not the investor: most of the money in any city comes from somewhere else, and the Where the money comes from section below shows exactly where it came from here.
Ranked by companies backed in this market and city, then by round count. "Led" counts rounds recorded with this investor as lead.
| # | Investor | Based in | Stages here | Companies | Rounds | Led | Latest | Portfolio total |
|---|---|---|---|---|---|---|---|---|
| 1 | Telegraph Hill Partners | San Francisco, United States | Series BSeries APE | 2 | 3 | — | Dec 2007 | 30 |
| 2 | Highland Capital Partners | Menlo Park, United States | Series BSeries DSeries C | 1 | 3 | 2 | Dec 2020 | 236 |
| 3 | Freestyle | Larkspur, United States | Series ASeries B | 1 | 3 | — | Jul 2021 | 117 |
| 4 | SV Angel | San Francisco, United States | Series ASeries B | 1 | 2 | — | Jul 2021 | 734 |
| 5 | FJ Labs | New York City, United States | SeedSeries A | 1 | 2 | — | Apr 2019 | 661 |
| 6 | F-Prime Capital | Cambridge, United States | Series ASeries B | 1 | 2 | 1 | Jul 2021 | 306 |
| 7 | Goodwater Capital | Burlingame, United States | Series BSeries D | 1 | 2 | 1 | Dec 2020 | 268 |
| 8 | S32 | Sunnyvale, United States | Series A | 1 | 2 | — | Apr 2019 | 82 |
| 9 | Next Coast Ventures | Austin, United States | Series BSeries D | 1 | 2 | — | Dec 2020 | 64 |
| 10 | Third Kind Venture Capital | New York City, United States | Series ASeries B | 1 | 2 | — | Jul 2021 | 69 |
| 11 | Slow Ventures | San Francisco, United States | SeedSeries A | 1 | 2 | — | Apr 2019 | 78 |
| 12 | NextGen Venture Partners | Baltimore, United States | SeedSeries B | 1 | 2 | 1 | Apr 2019 | 56 |
| 13 | SoGal Ventures | New York City, United States | SeedSeries B | 1 | 2 | — | Apr 2019 | 23 |
| 14 | Growth Capital Fund | Houston, United States | Series BSeries A | 1 | 2 | — | Dec 2007 | 3 |
| 15 | Lux Capital | Menlo Park, United States | Series D | 1 | 1 | 1 | Dec 2020 | 282 |
| 16 | SoftBank Vision Fund | London, United Kingdom | Series B | 1 | 1 | 1 | Jul 2021 | 325 |
| 17 | Founder Collective | Cambridge, United States | Series A | 1 | 1 | 1 | Jul 2017 | 336 |
| 18 | BlackRock | New York City, United States | Series D | 1 | 1 | 1 | Dec 2020 | 283 |
| 19 | Slow Ventures | New York City, United States | Series B | 1 | 1 | — | Jul 2021 | 198 |
| 20 | Frazier Healthcare Partners | Seattle, United States | Series B | 1 | 1 | — | May 2007 | 118 |
| 21 | Foresite Capital | New York City, United States | Series D | 1 | 1 | 1 | Dec 2020 | 116 |
| 22 | Greenspring Associates | Owings Mills, United States | Series D | 1 | 1 | 1 | Dec 2020 | 112 |
| 23 | Austin Technology Incubator | Austin, United States | Seed | 1 | 1 | 1 | Sep 2016 | 148 |
| 24 | Morningside | Newton, United States | Series D | 1 | 1 | 1 | Dec 2020 | 101 |
| 25 | Health Quest Capital | Belmont, United States | Series D | 1 | 1 | 1 | Jan 2021 | 38 |
| 26 | Portfolia | Menlo Park, United States | Series D | 1 | 1 | 1 | Dec 2020 | 47 |
| 27 | PTV Healthcare Capital | Austin, United States | Series B | 1 | 1 | — | Dec 2007 | 11 |
| 28 | TCG | Washington, DC, United States | Series D | 1 | 1 | 1 | Dec 2020 | 11 |
| 29 | AGO Partners | Los Angeles, United States | Seed | 1 | 1 | — | Mar 2016 | 10 |
| 30 | Capstar Partners | Austin, United States | Seed | 1 | 1 | 1 | Jan 2018 | 5 |
| 31 | Inception Capital Management | Kirkland, United States | Seed | 1 | 1 | 1 | Nov 2016 | 4 |
| 32 | Notley | Austin | Seed | 1 | 1 | — | Mar 2016 | 4 |
| 33 | Full Tilt Capital | Valrico, United States | Seed | 1 | 1 | — | May 2017 | 4 |
| 34 | Fusion Capital | Nairobi, Kenya | Series B | 1 | 1 | — | 2 | |
| 35 | Genie Healthcare | East Windsor | Seed | 1 | 1 | 1 | Aug 2025 | 1 |
Head office of the investors on this page.
Rounds by stage — where in a company's life this money arrives.
Total disclosed size of each round, not one investor's share.
How active this market has been.
Genomics companies head-officed in Austin that took money from these investors.
| Company | Backers | Rounds | Disclosed | Latest round |
|---|---|---|---|---|
| Everlywell everlywell.com |
14 | 20 | $2.1B | Series D Jan 2021 |
| Embark Veterinary embarkvet.com |
12 | 20 | $550M | Series B Jul 2021 |
| Asuragen asuragen.com |
3 | 5 | $153.5M | Series B Dec 2007 |
| Endocare endocare.com |
2 | 2 | $21.5M | Series B May 2007 |
| Ambion ambion.com |
1 | 1 | $10.5M | PE May 2003 |
| Wellnicity wellnicity.com |
1 | 1 | $3.6M | Seed Jan 2018 |
| Genprex genprex.com |
1 | 1 | $950K | Seed Nov 2016 |
| AptamiR Therapeutics aptamir.com |
1 | 1 | — | Seed Sep 2016 |
| Vizzhy vizzhy.com |
1 | 1 | — | Seed Aug 2025 |
| Date | Investor | Company | Stage | Round size |
|---|---|---|---|---|
| Aug 2025 | Genie HealthcareLED | Vizzhy | Seed | — |
| Jul 2021 | Slow Ventures | Embark Veterinary | Series B | $75M |
| Jul 2021 | SV Angel | Embark Veterinary | Series B | $75M |
| Jul 2021 | Freestyle | Embark Veterinary | Series B | $75M |
| Jul 2021 | F-Prime Capital | Embark Veterinary | Series B | $75M |
| Jul 2021 | Third Kind Venture Capital | Embark Veterinary | Series B | $75M |
| Jul 2021 | SoftBank Vision FundLED | Embark Veterinary | Series B | $75M |
| Jan 2021 | Health Quest CapitalLED | Everlywell | Series D | $75M |
| Dec 2020 | Goodwater Capital | Everlywell | Series D | $175M |
| Dec 2020 | PortfoliaLED | Everlywell | Series D | $175M |
| Dec 2020 | Highland Capital Partners | Everlywell | Series D | $175M |
| Dec 2020 | BlackRockLED | Everlywell | Series D | $175M |
| Dec 2020 | Lux CapitalLED | Everlywell | Series D | $175M |
| Dec 2020 | Greenspring AssociatesLED | Everlywell | Series D | $175M |
| Dec 2020 | MorningsideLED | Everlywell | Series D | $175M |
| Dec 2020 | Foresite CapitalLED | Everlywell | Series D | $175M |
| Dec 2020 | TCGLED | Everlywell | Series D | $175M |
| Dec 2020 | Next Coast Ventures | Everlywell | Series D | $175M |
| Feb 2020 | Highland Capital PartnersLED | Everlywell | Series C | $25M |
| Apr 2019 | Goodwater CapitalLED | Everlywell | Series B | $50M |
Genomics investors in other cities
Other markets in Austin